Xu J - Search Results

1

In vivo Evaluation of a Newly Synthesized Acetylcholinesterase Inhibitor in a Transgenic Drosophila Model of Alzheimer's Disease.

Uras G, Manca A, Zhang P, Markus Z, Mack N, Allen S, Bo M, Xu S, Xu J, Georgiou M, Zhu Z. Uras G, et al. Among authors: xu s, xu j. Front Neurosci. 2021 Jun 30;15:691222. doi: 10.3389/fnins.2021.691222. eCollection 2021. Front Neurosci. 2021. PMID: 34276297 Free PMC article.

2

The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.

Wang L, Li D, Xu S, Cai H, Yao H, Zhang Y, Jiang J, Xu J. Wang L, et al. Among authors: xu s, xu j. Eur J Med Chem. 2012 Jun;52:242-50. doi: 10.1016/j.ejmech.2012.03.024. Epub 2012 Mar 23. Eur J Med Chem. 2012. PMID: 22483090

3

Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents.

Li D, Xu S, Cai H, Pei L, Wang L, Wu X, Yao H, Jiang J, Sun Y, Xu J. Li D, et al. Among authors: xu s, xu j. ChemMedChem. 2013 May;8(5):812-8. doi: 10.1002/cmdc.201200559. Epub 2013 Mar 20. ChemMedChem. 2013. PMID: 23520191

4

Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.

Li D, Xu S, Cai H, Pei L, Zhang H, Wang L, Yao H, Wu X, Jiang J, Sun Y, Xu J. Li D, et al. Among authors: xu s, xu j. Eur J Med Chem. 2013 Jun;64:215-21. doi: 10.1016/j.ejmech.2013.04.012. Epub 2013 Apr 11. Eur J Med Chem. 2013. PMID: 23644204

5

Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates.

Liu J, Liu Q, Yang X, Xu S, Zhang H, Bai R, Yao H, Jiang J, Shen M, Wu X, Xu J. Liu J, et al. Among authors: xu s, xu j. Bioorg Med Chem. 2013 Dec 15;21(24):7742-51. doi: 10.1016/j.bmc.2013.10.017. Epub 2013 Oct 23. Bioorg Med Chem. 2013. PMID: 24200932

6

Synthesis and β-adrenergic blocking activity of oxime ether hybrids derived from a natural isochroman-4-one.

Bai RR, Xu ST, Liu J, Hong W, Tang YQ, Wu XM, Xie WJ, Yao HQ, Xu JY. Bai RR, et al. Among authors: xu jy, xu st. Chin J Nat Med. 2013 Sep;11(5):538-45. doi: 10.1016/S1875-5364(13)60098-9. Chin J Nat Med. 2013. PMID: 24359781

7

Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives.

Xu S, Li D, Pei L, Yao H, Wang C, Cai H, Yao H, Wu X, Xu J. Xu S, et al. Among authors: xu j. Bioorg Med Chem Lett. 2014 Jul 1;24(13):2811-4. doi: 10.1016/j.bmcl.2014.04.119. Epub 2014 May 9. Bioorg Med Chem Lett. 2014. PMID: 24835198

8

Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.

Xu S, Pei L, Wang C, Zhang YK, Li D, Yao H, Wu X, Chen ZS, Sun Y, Xu J. Xu S, et al. Among authors: xu j. ACS Med Chem Lett. 2014 May 28;5(7):797-802. doi: 10.1021/ml500141f. eCollection 2014 Jul 10. ACS Med Chem Lett. 2014. PMID: 25050168 Free PMC article.

9

Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives.

Zhang H, Zhu P, Liu J, Yang X, Xu S, Yao H, Jiang J, Ye W, Wu X, Xu J. Zhang H, et al. Among authors: xu s, xu j. Eur J Med Chem. 2014 Nov 24;87:159-67. doi: 10.1016/j.ejmech.2014.09.058. Epub 2014 Sep 18. Eur J Med Chem. 2014. PMID: 25247772

10

Synthesis and antimycobacterial evaluation of natural oridonin and its enmein-type derivatives.

Xu S, Pei L, Li D, Yao H, Cai H, Yao H, Wu X, Xu J. Xu S, et al. Among authors: xu j. Fitoterapia. 2014 Dec;99:300-6. doi: 10.1016/j.fitote.2014.10.005. Epub 2014 Oct 12. Fitoterapia. 2014. PMID: 25316557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,206 results

Search Page

Filters